Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response

Cell Res. 2015 Feb;25(2):225-36. doi: 10.1038/cr.2015.8. Epub 2015 Jan 20.

Abstract

Ataxia telangiectasia mutated (ATM) mediates DNA damage response by controling irradiation-induced foci formation, cell cycle checkpoint, and apoptosis. However, how upstream signaling regulates ATM is not completely understood. Here, we show that upon irradiation stimulation, ATM associates with and is phosphorylated by epidermal growth factor receptor (EGFR) at Tyr370 (Y370) at the site of DNA double-strand breaks. Depletion of endogenous EGFR impairs ATM-mediated foci formation, homologous recombination, and DNA repair. Moreover, pretreatment with an EGFR kinase inhibitor, gefitinib, blocks EGFR and ATM association, hinders CHK2 activation and subsequent foci formation, and increases radiosensitivity. Thus, we reveal a critical mechanism by which EGFR directly regulates ATM activation in DNA damage response, and our results suggest that the status of ATM Y370 phosphorylation has the potential to serve as a biomarker to stratify patients for either radiotherapy alone or in combination with EGFR inhibition.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Ataxia Telangiectasia Mutated Proteins / metabolism*
  • Cell Line, Tumor
  • Checkpoint Kinase 2 / metabolism
  • DNA Breaks, Double-Stranded / radiation effects
  • DNA Repair* / drug effects
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism
  • Gefitinib
  • HeLa Cells
  • Humans
  • Phosphorylation / drug effects
  • Phosphorylation / radiation effects
  • Quinazolines / pharmacology
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Radiation, Ionizing
  • Signal Transduction / drug effects
  • Tyrosine / metabolism*

Substances

  • Quinazolines
  • RNA, Small Interfering
  • Tyrosine
  • Checkpoint Kinase 2
  • ErbB Receptors
  • Ataxia Telangiectasia Mutated Proteins
  • Gefitinib